Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines

Rebecca Kahn, Stephanie J. Schrag, Jennifer R. Verani, Marc Lipsitch
doi: https://doi.org/10.1101/2021.07.15.21260595

Article Information

doi 
https://doi.org/10.1101/2021.07.15.21260595
History 
  • July 19, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Rebecca Kahn1,*,
  2. Stephanie J. Schrag2,
  3. Jennifer R. Verani2 and
  4. Marc Lipsitch1,3
  1. 1Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  2. 2COVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia
  3. 3Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  1. ↵* Corresponding author; email: rek160{at}mail.harvard.edu
Back to top
Posted July 19, 2021.
Download PDF
Data/Code
Email
Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines
Rebecca Kahn, Stephanie J. Schrag, Jennifer R. Verani, Marc Lipsitch
medRxiv 2021.07.15.21260595; doi: https://doi.org/10.1101/2021.07.15.21260595
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area